PHF6 and acute myeloid leukemia: Recently, mutant WT1 has been also associated with NPM1 as secondary mutations; while when WT1 occurs as a secondary mutation, the most common dominant alterations are in DNMT3A, which also negatively affects prognosis of AML patients, PHF6, FLT3, and CEBPA [26].